MedTrace Logo

Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?

NCT01288924 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2016-12-06

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of parecoxib with placebo on the incidence and severity of postthoracotomy shoulder pain, the amount of analgesic requirement for relieving severity of postthoracotomy shoulder pain and adverse events associated with treatment.

Conditions

  • Shoulder Pain
  • Post-operative Pain

Interventions

DRUG

Parecoxib

Parecoxib 40 mg intravenous before surgery and every 12 hours for two days.

OTHER

Control

NSS 2 ml intravenous before surgery and every 12 hours for two days.

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Tanyong Pipanmekaporn, MD · Department of Anesthesiology, Faculty of Medicine, Chiang Mai University , Chiang Mai, Thailand,50200

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-10-31
Completion
2016-01-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01288924 on ClinicalTrials.gov